Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.
April 2024

What Should Prescribers and Policy Makers Know About US Drug Importation?

AMA Journal of Ethics

In the AMA Journal of Ethics, senior manager Nisha Quasba and director Elliot Vice discuss key points to consider, especially from a policy perspective, when weighing imported medicines’ perceived affordability and accessibility against additional resource expenditure needed to assure sufficient regulatory oversight and equitable distribution and to mitigate potential risks of harm to patients.

Quasba and Vice note how drug importation raises several ethical and safety concerns relevant to prescribers and policy makers considering the costs and benefits of international medicine importation. The authors also offer insight to federal drug importation regulation, counterfeit drug risks and online pharmacies.

Full Article

Meet the Authors

Related Legal Services

Related Policy, Advocacy, and Consulting Services

Related Industries

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.